Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0039-2025

Drug recall · November 13, 2024

Regadenoson Injection recall

Why: Labeling: Missing Label

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

Lots / codes

Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025

Quantity
60,594 units
Company
Baxter Healthcare Corporation, Deerfield, IL
Distribution
Nationwide within the USA
Initiated
October 30, 2024 · Voluntary: Firm initiated
Classified
November 6, 2024
Reported
November 13, 2024
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.